INTRODUCTION: Leukocyte adhesion deficiency (LAD) is a group of rare inherited disorders characterized by immune deficiency and peripheral neutrophilia. There are only seven reported cases of LAD type II worldwide, and no long-term follow-up data. CASE REPORT: We reviewed the medical file of a 20-year-old man with LAD II. Clinical characteristics included short stature, severe mental retardation, and autistic features. He had had no severe infections since infancy, and his current immunological status was stable. The last laboratory work-up revealed mild leukocytosis and neutrophilia. Genetic analysis of the Golgi GDP-fucose transporter (GFTP) sequence yielded a point mutation resulting in Y337C amino acid transition in the tenth transmembrane domain. CONCLUSION: In conclusion, in LAD II, the main clinical countenance shifts from frequent infections due to immunodeficiency in the early years to the metabolic consequences of the defect in fucose metabolism, i.e., retarded growth and mental retardation, in the later years. A novel mutation in the GFTP loci associated with LAD II is described.
INTRODUCTION:Leukocyte adhesion deficiency (LAD) is a group of rare inherited disorders characterized by immune deficiency and peripheral neutrophilia. There are only seven reported cases of LAD type II worldwide, and no long-term follow-up data. CASE REPORT: We reviewed the medical file of a 20-year-old man with LAD II. Clinical characteristics included short stature, severe mental retardation, and autistic features. He had had no severe infections since infancy, and his current immunological status was stable. The last laboratory work-up revealed mild leukocytosis and neutrophilia. Genetic analysis of the Golgi GDP-fucose transporter (GFTP) sequence yielded a point mutation resulting in Y337C amino acid transition in the tenth transmembrane domain. CONCLUSION: In conclusion, in LAD II, the main clinical countenance shifts from frequent infections due to immunodeficiency in the early years to the metabolic consequences of the defect in fucose metabolism, i.e., retarded growth and mental retardation, in the later years. A novel mutation in the GFTP loci associated with LAD II is described.
Authors: A Etzioni; M Frydman; S Pollack; I Avidor; M L Phillips; J C Paulson; R Gershoni-Baruch Journal: N Engl J Med Date: 1992-12-17 Impact factor: 91.245
Authors: M Aebi; A Helenius; B Schenk; R Barone; A Fiumara; E G Berger; T Hennet; T Imbach; A Stutz; C Bjursell; A Uller; J G Wahlström; P Briones; E Cardo; P Clayton; B Winchester; V Cormier-Dalre; P de Lonlay; M Cuer; T Dupré; N Seta; T de Koning; L Dorland; F de Loos; L Kupers Journal: Glycoconj J Date: 1999-11 Impact factor: 2.916
Authors: Thomas R Bauer; James M Allen; Mehreen Hai; Laura M Tuschong; Iram F Khan; Erik M Olson; Rima L Adler; Tanya H Burkholder; Yu-Chen Gu; David W Russell; Dennis D Hickstein Journal: Nat Med Date: 2007-12-23 Impact factor: 53.440
Authors: M Frydman; A Etzioni; T Eidlitz-Markus; I Avidor; I Varsano; Y Shechter; J B Orlin; R Gershoni-Baruch Journal: Am J Med Genet Date: 1992-10-01
Authors: Edith van de Vijver; Anne Maddalena; Özden Sanal; Steven M Holland; Gulbu Uzel; Manisha Madkaikar; Martin de Boer; Karin van Leeuwen; M Yavuz Köker; Nima Parvaneh; Alain Fischer; S K Alex Law; Nigel Klein; F Ilhan Tezcan; Ekrem Unal; Turkan Patiroglu; Bernd H Belohradsky; Klaus Schwartz; Raz Somech; Taco W Kuijpers; Dirk Roos Journal: Blood Cells Mol Dis Date: 2011-11-30 Impact factor: 3.039
Authors: Christoph Geisler; Varshika Kotu; Mary Sharrow; Dubravko Rendić; Gerald Pöltl; Michael Tiemeyer; Iain B H Wilson; Donald L Jarvis Journal: J Biol Chem Date: 2012-06-28 Impact factor: 5.157